Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Favorite
Like
Tweet
Print
Scott Lazerwith, Ph.D.
Gilead Sciences, Inc.
Poster(s):
(T1230-10-68) Mechanistic Elucidation of Pharmacokinetic Effects of Target-Mediated Drug Disposition (TMDD) for Small Molecule VAP-1 Inhibitor
Tuesday, October 24, 2023
12:30 PM – 1:30 PM
ET
